Table 1.
Baseline demographics and characteristics
| Characteristic | ADAew (N = 15) |
|---|---|
| Sex, n (%) | |
| Female | 2 (13.3) |
| Male | 13 (86.7) |
| Race, Asian, n (%) | 15 (100) |
| BMI, kg/m2, n (%) | |
| Normal (<25) | 7 (46.7) |
| Overweight (25 to <30) | 4 (26.7) |
| Obese (30 to <40) | 2 (13.3) |
| Morbidly obese (≥40) | 2 (13.3) |
| Tobacco use, n (%) | |
| Current | 12 (80) |
| Former | 1 (6.7) |
| Never | 2 (13.3) |
| Hurley stage, n (%) | |
| II | 9 (60) |
| III | 6 (40) |
| HS family history, n (%) | |
| Yes | 1 (6.7) |
| No | 14 (93.3) |
| Prior HS medication, n (%) | |
| Antibiotic | 8 (53.3) |
| Other | |
| Topical | 5 (33.3) |
| Systemic | 1 (6.7) |
| Prior HS surgery, n (%) | |
| Yes | 6 (40) |
| No | 9 (60) |
| Age, years, median (range) | 44 (26–52) |
| BMI, kg/m2, median (range) | 26.5 (18.1–50.6) |
| Lesion count, median (range) | |
| Abscess | 2 (0–13) |
| Draining fistula | 2 (0–15) |
| Non‐draining fistula | 7 (0–19) |
| Inflammatory nodule | 6 (1–21) |
| Hypertrophic scar | 6 (0–35) |
| Modified Sartorius score,† median (range) | 111 (72–286) |
| Duration of HS, years, median (range) | 11.7 (0.9–33.1) |
| DLQI score,‡ (median, range) | 6 (0–15) |
| C‐reactive protein, mg/L, (median, range) | 3.1 (0.2–41.2) |
| HS pain at worst, NRS (median, range)§ | 4 (0–5.6) |
†Range 0 to no upper limit. ‡Range 0–30. §Range 0–10. ADA, adalimumab; BMI, body mass index; DLQI, Dermatology Life Quality Index; ew, every‐week dosing; HS, hidradenitis suppurativa; NRS, Numerical Rating Scale.